Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention

about

Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention

Item

http://www.wikidata.org/entity/Q35573604

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Percutaneous ethanol injection ...... y for Parathyroid Intervention

@ast

Percutaneous ethanol injection ...... y for Parathyroid Intervention

@en

type

Item

label

Percutaneous ethanol injection ...... y for Parathyroid Intervention

@ast

Percutaneous ethanol injection ...... y for Parathyroid Intervention

@en

prefLabel

Percutaneous ethanol injection ...... y for Parathyroid Intervention

@ast

Percutaneous ethanol injection ...... y for Parathyroid Intervention

@en

P1476

Percutaneous ethanol injection ...... y for Parathyroid Intervention

@en

P2093

Fumihiko Koiwa

http://www.w3.org/2001/XMLSchema#string

Japanese Society for Parathyroid Intervention

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Kurokawa

http://www.w3.org/2001/XMLSchema#string

Masafumi Kitaoka

http://www.w3.org/2001/XMLSchema#string

Noritaka Onoda

http://www.w3.org/2001/XMLSchema#string

Tadao Akizawa

http://www.w3.org/2001/XMLSchema#string

Takatoshi Kakuta

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Tominaga

http://www.w3.org/2001/XMLSchema#string

P2860

Surgical management of secondary hyperparathyroidism in uremia.

Medical and surgical aspects of parathyroidectomy.

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism.

An overview of regular dialysis treatment in Japan (as of 31 December 2002).

Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients.

Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.

Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia.

Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism.

P304

iii21-iii25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDTPLUS/SFN082

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masafumi Fukagawa

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237655757

http://www.w3.org/2001/XMLSchema#string

P698

25983968

http://www.w3.org/2001/XMLSchema#string

P921

hyperparathyroidism

P932

4421128

http://www.w3.org/2001/XMLSchema#string